Microbiome therapies: a maturing movement
European Pharmaceutical Review
JUNE 27, 2023
Riding on the momentum of the first faecal microbiota product approved for C. At MaaT Pharma our donor-derived products are made through pooling (ie, mixing multiple donors), thus achieving a higher overall richness and standardisation of the resulting drug product. coli strains in the gut”.
Let's personalize your content